Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies

[1]  A. Jenkins,et al.  C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort. , 2009, Clinical chemistry.

[2]  P. Ridker,et al.  Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. , 2009, Clinical chemistry.

[3]  T. Erlinger,et al.  C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies , 2008, International journal of cancer.

[4]  X. Shu,et al.  Intra-individual Variation of Plasma Adipokine Levels and Utility of Single Measurement of These Biomarkers in Population-Based Studies , 2007, Cancer Epidemiology Biomarkers & Prevention.

[5]  S. Kagamimori,et al.  Intra-individual variability of high-sensitivity C-reactive protein: age-related variations over time in Japanese subjects. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Paul M Ridker,et al.  C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.

[7]  H. Boshuizen,et al.  Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[8]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[9]  W. Koenig,et al.  Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. , 2003, American journal of epidemiology.

[10]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[11]  N Rifai,et al.  High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. , 2001, Clinical chemistry.

[12]  P. Ridker,et al.  Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. , 2001, Clinical chemistry.

[13]  K. Kario,et al.  Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993-1998. , 2000, Japanese circulation journal.

[14]  M. Pfeffer,et al.  Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .

[15]  L. Kuller,et al.  Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. , 1999, American journal of epidemiology.

[16]  C. Kluft,et al.  Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J. Manson,et al.  Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  C. Fraser,et al.  Biological Variation of Acute Phase Proteins , 1993, Annals of clinical biochemistry.

[19]  B Rosner,et al.  Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. , 1992, American journal of epidemiology.

[20]  A. Maseri,et al.  [The JUPITER study]. , 2009, Giornale italiano di cardiologia.

[21]  P. Ridker,et al.  Tracking of High-Sensitivity C-Reactive Protein after Observation of an Initially Increased Concentration: The JUPITER Study , 2008 .

[22]  M. Pfeffer,et al.  Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. , 1999, Circulation.

[23]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.